By downregulating PRLR, Osthole disrupts the ligand-dependent activation of JAK2, leading to reduced STAT3 phosphorylation — a critical event in tumor cell proliferation and resistance to apoptosis. This evidence concerns the gene JAK2 and neoplasm.